Scott Brunner of the Alliance for Pharmacy Compounding has described this as the start of a "protracted process." Even under the most optimistic scenario, broad clinical availability of legally compounded versions of these peptides is likely a mid-to-late 2026 proposition at the earliest and possibly longer if the political or regulatory environment shifts
Certain groups may need to take a B12 supplement for life
In data analysis, the elimination half-life of cagrilintide was found to be 78 days, with maximum exposure 2425 hours after administration, making it suitable for once-weekly dosing
And if, say, a cancer patient could demonstrate that BPC-157 use accelerated their tumor (a very difficult causal link to prove scientifically, but hypothetically), the liability could be enormous
Different formulations have differences in drug release, absorption, site of action, and ease of use